SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The Revenue for the quarter ended  June 2024 of Rs. 128.89 millions grew by 21.81 % from Rs. 105.81 millions.The Net Loss for the quarter ended June 2024 is Rs. -51.71 millions as compared to Net Loss of Rs. -53.32 millions of corresponding quarter ended June 2023 Operating profit Margin for the quarter ended June 2024 improved to -21.63% as compared to -25.82% of corresponding quarter ended June 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 128.89 105.81 21.81 128.89 105.81 21.81 504.22 521.34 -3.28
Other Income 0.34 0.38 -10.53 0.34 0.38 -10.53 4.51 6.20 -27.26
PBIDT -21.63 -25.82 -16.23 -21.63 -25.82 -16.23 -82.72 -151.59 -45.43
Interest 13.18 10.97 20.15 13.18 10.97 20.15 46.89 29.73 57.72
PBDT -34.81 -36.79 -5.38 -34.81 -36.79 -5.38 -129.61 -181.32 -28.52
Depreciation 16.90 16.53 2.24 16.90 16.53 2.24 67.66 65.59 3.16
PBT -51.71 -53.32 -3.02 -51.71 -53.32 -3.02 -197.27 -246.91 -20.10
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -51.71 -53.32 -3.02 -51.71 -53.32 -3.02 -197.27 -246.91 -20.10
Equity 215.61 215.61 0.00 215.61 215.61 0.00 215.61 215.61 0.00
PBIDTM(%) -16.78 -24.40 -31.23 -16.78 -24.40 -31.23 -16.41 -29.08 -43.58

Krebs Biochem.&Inds Share Price

58.97 0.63 (1.08%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×